Hans-Peter Hasler

Hans-Peter Hasler

Fortune : 3 M $ au 31/08/2026

70 ans
Health Technology
Commercial Services
Miscellaneous

Profil

Hans-Peter Hasler is the founder of Vicarius Pharma AG, founded in 2016, where the title held is Director since 2020.
Current jobs include Chairman at HBM Healthcare Investments AG since 2009; Non-Executive Chairman at Shield Therapeutics Plc since 2020; Chairman at Medical Imaging Analysis Center since 2012; Independent Director at Gain Therapeutics, Inc. since 2021; Independent Director at Minerva Neurosciences, Inc. since 2017; and Principal at Hph Management GmbH.
Former jobs include Vice Chairman at Santhera Pharmaceuticals Holding AG from 2006 to 2011; Director at Acino International AG from 2008 to 2013; Independent Non-Executive Director at Dr. Reddy's Laboratories Ltd. from 2016 to 2018; Managing Director at Wyeth Pharma GmbH; Director at Ferring Holding SA; Director at Ferring International Center SA; Independent Director at Celltrion, Inc.; Managing Director at Wyeth Pharmaceuticals AG from 1993 to 1998; Director at Canyon Pharmaceuticals AG; Director at AOP Orphan Pharmaceuticals GmbH; Managing Director at Wyeth-lederle Pharma GmbH; Director at Dr. Reddy's Laboratories SA; Independent Non-Executive Director at Patheon NV from 2016 to 2017; Director at Rigi Healthcare AG; Chief Marketing Officer at Wyeth LLC; Executive Vice President-International at Biogen MA, Inc.; Chief Operating Officer at Elan Corp.
Plc from 2012 to 2014; COO, EVP, Head-Global Neurology & International at Biogen, Inc. from 2003 to 2009; Chief Marketing Officer & Senior Vice President at Wyeth Pharmaceuticals LLC from 1998 to 2001; Chief Operating Officer at Biogen Idec, Inc. (North Carolina) from 2001 to 2009.
Education includes undergraduate studies at Schweizerisches Institut für Betriebsökonomie AG.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2025 10 147 ( 0,15 % ) 3 M $ 31/08/2026
31/12/2025 5 500 000 ( 0,51 % ) 455 400 $ 31/08/2026
03/06/2026 1 250 ( 0 % ) 5 700 $ 31/08/2026
15/07/2026 0 ( -.--% ) - $ 31/08/2026

Postes actifs de Hans-Peter Hasler

SociétésPosteDébut
HBM HEALTHCARE INVESTMENTS AG Président 01/06/2009
MINERVA NEUROSCIENCES, INC. Directeur/Membre du Conseil 10/12/2017
SHIELD THERAPEUTICS PLC Président 18/06/2020
GAIN THERAPEUTICS, INC. Directeur/Membre du Conseil 01/03/2021
Fondateur 01/04/2016
Corporate Officer/Principal -
Medical Imaging Analysis Center
Président 01/12/2012

Anciens postes connus de Hans-Peter Hasler

SociétésPosteFin
DR. REDDY'S LABORATORIES LIMITED Directeur/Membre du Conseil 14/06/2018
PATHEON N.V. Directeur/Membre du Conseil 29/08/2017
░░░░ ░░░░░ ░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Hans-Peter Hasler

Formation de Hans-Peter Hasler

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées28

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Wyeth Pharmaceuticals AG

Consumer Services

Canyon Pharmaceuticals AG

Health Technology

Wyeth-lederle Pharma GmbH

Health Technology

Health Technology

Health Technology

Health Technology

Medical Imaging Analysis Center

Commercial Services

Commercial Services

Rigi Healthcare AG

Health Technology

  1. Bourse
  2. Insiders
  3. Hans-Peter Hasler
🔇